Skip NavigationSkip to Content
Return Return to Search Results

Effect of Calcium Carbonate Encapsulation on the Activity of Orally Administered CpG Oligonucleotides

  1. Author:
    Kayraklioglu, Neslihan
    Scheiermann, Julia
    Alvord, W. Gregory
    Klinman, Dennis

  2. Author Address

    NCI, Frederick Natl Lab Canc Res, NIH, Frederick, MD 21702 USA.Hacettepe Univ, Canc Inst, Dept Basic Oncol, TR-06100 Ankara, Turkey.NCI, DMS Appl Informat & Management Sci, NIH, Frederick, MD 21702 USA.
    1. Year: 2017
    2. Date: Sep 15
  2. Journal: MOLECULAR THERAPY-NUCLEIC ACIDS
  3. CELL PRESS,
    1. 8
    2. Pages: 243-249
  5. Type of Article: Article
  6. ISSN: 2162-2531
  1. Abstract:

    Synthetic oligodeoxynucleotides containing unmethylated CpG motifs (CpG ODNs) stimulate immune cells via Toll-like receptor 9 (TLR9). Because oligodeoxynucleotides (ODNs) are susceptible to gastric degradation, clinical trials designed to evaluate their therapeutic utility have relied solely on parenteral routes of administration. A strategy to improve the activity of orally delivered ODNs by reducing their susceptibility to gastrointestinal (GI) digestion via encapsulation in calcium carbonate nanoparticles (ODNcaps) was recently described. This study compares the in vitro and in vivo activity of encapsulated (ODNcaps) versus free CpG ODNs delivered orally or parenterally. ODNcaps mirrored the ability of free ODNs to stimulate splenic B cells and macrophages in vitro. ODNcaps activated immune cells in the Peyer's patches and mesenteric lymph nodes after oral delivery. Their effect on GI immunity was evaluated in studies of dextran sulfate sodium (DSS)-induced colitis and enteric infection, whereas systemic immunity was examined by monitoring their effect on lipopolysaccharide (LPS)-induced cytokine production and systemic pathogen challenge. Results indicate that orally delivered CpG ODNs predominantly induce GI rather than systemic immunity, and that calcium carbonate encapsulation does not significantly alter this behavior.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1016/j.omtn.2017.06.015
  3. PMID: 28918025
  4. PMCID: PMC5508619
  5. View record in Web of Science®
  6. WOS: 000405214800001

Library Notes

  1. Fiscal Year: FY2016-2017
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel